Sep 13, 2011
Follow-up Study to RV144 HIV Vaccine Trial Shows No Effect on Disease Progression in Infected Volunteers
Sep 28, 2010
A Phase I study, RV262, recently began to evaluate a combination DNA prime/MVA vector boost vaccine regimen that was developed to protect against diverse subtypes of HIV.
Oct 20, 2009
Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conference Provide Insight for Future Research
Sep 24, 2009
HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV